• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA:肝脏疾病的风尚还是未来。

microRNAs: fad or future of liver disease.

机构信息

Department of Biology, University of North Carolina at Charlotte, Charlotte, 28223 NC, United States.

出版信息

World J Gastroenterol. 2011 May 28;17(20):2536-42. doi: 10.3748/wjg.v17.i20.2536.

DOI:10.3748/wjg.v17.i20.2536
PMID:21633658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3103811/
Abstract

microRNAs (miRs) are small non-coding RNAs that regulate both mRNA and protein expression of target genes, which results in alterations in mRNA stability or translation inhibition. miRs influence at least one third of all human transcripts and are known regulators of various important cellular growth and differentiation factors. miRs have recently emerged as key regulatory molecules in chronic liver disease. This review details recent contributions to the field of miRs that influence liver development and the broad spectrum of disease, from non-alcoholic fatty liver disease to fibrosis/cirrhosis, with particular emphasis on hepatic stellate cells and potential use of miRs as therapeutic tools.

摘要

microRNAs (miRs) 是小的非编码 RNA,可调节靶基因的 mRNA 和蛋白质表达,从而导致 mRNA 稳定性或翻译抑制的改变。miRs 影响至少三分之一的人类转录物,是各种重要细胞生长和分化因子的已知调节剂。miRs 最近已成为慢性肝病的关键调节分子。本综述详细介绍了影响肝脏发育和广泛疾病的 miR 的最新研究进展,从非酒精性脂肪性肝病到纤维化/肝硬化,特别强调了肝星状细胞和 miR 作为治疗工具的潜在用途。

相似文献

1
microRNAs: fad or future of liver disease.微小 RNA:肝脏疾病的风尚还是未来。
World J Gastroenterol. 2011 May 28;17(20):2536-42. doi: 10.3748/wjg.v17.i20.2536.
2
MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis.微小 RNA 在非酒精性脂肪性肝病和肝纤维化进行性肝损伤发病机制及治疗中的作用
Adv Drug Deliv Rev. 2018 Apr;129:54-63. doi: 10.1016/j.addr.2018.01.009. Epub 2018 Jan 31.
3
Nuclear receptors in liver disease.核受体与肝脏疾病。
Hepatology. 2011 Mar;53(3):1023-34. doi: 10.1002/hep.24148. Epub 2011 Feb 11.
4
MicroRNAs in liver disease.微小 RNA 与肝脏疾病。
Gastroenterology. 2012 Jun;142(7):1431-43. doi: 10.1053/j.gastro.2012.04.007. Epub 2012 Apr 11.
5
MicroRNAs in Liver Disease: Bench to Bedside.肝病中的微小RNA:从 bench 到 bedside。 (注:bench一般指实验室工作台,这里表示基础研究;bedside表示临床应用,整体意思是从基础研究到临床应用 )
J Clin Exp Hepatol. 2013 Sep;3(3):231-42. doi: 10.1016/j.jceh.2013.09.001. Epub 2013 Sep 17.
6
MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives.非酒精性脂肪性肝病中的 microRNAs:进展与展望。
Mol Metab. 2022 Nov;65:101581. doi: 10.1016/j.molmet.2022.101581. Epub 2022 Aug 23.
7
Non-coding RNA-mediated epigenetic regulation of liver fibrosis.非编码 RNA 介导的肝纤维化表观遗传调控。
Metabolism. 2015 Nov;64(11):1386-94. doi: 10.1016/j.metabol.2015.08.004. Epub 2015 Aug 14.
8
Regulation of microRNAs and their role in liver development, regeneration and disease.微小RNA的调控及其在肝脏发育、再生和疾病中的作用。
Int J Biochem Cell Biol. 2014 Sep;54:288-303. doi: 10.1016/j.biocel.2014.04.002. Epub 2014 Apr 13.
9
Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human.循环肝脏特异性 microRNAs 作为人类肝脏疾病的非侵入性诊断生物标志物。
Biomarkers. 2019 Mar;24(2):103-109. doi: 10.1080/1354750X.2018.1528631. Epub 2018 Oct 23.
10
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.miR-19b 对肝星状细胞介导的肝纤维化形成的抑制作用。
Hepatology. 2012 Jul;56(1):300-10. doi: 10.1002/hep.25613. Epub 2012 Jun 18.

引用本文的文献

1
Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs.探讨非编码 RNA 在非酒精性脂肪性肝病中的调控作用:特别关注过氧化物酶体增殖物激活受体。
Cells. 2022 Dec 7;11(24):3959. doi: 10.3390/cells11243959.
2
The relationship between polyphenols and miRNAs: A novel therapeutic strategy for metabolic associated fatty liver disease.多酚与微小RNA之间的关系:代谢相关脂肪性肝病的一种新型治疗策略。
Hepatol Forum. 2021 Sep 15;2(3):128-136. doi: 10.14744/hf.2021.2021.0037. eCollection 2021 Sep.
3
MicroRNA-506-3p targets SIRT1 and suppresses AMPK pathway activation to promote hepatic steatosis.微小RNA-506-3p靶向沉默调节蛋白1并抑制AMPK信号通路激活以促进肝脂肪变性。
Exp Ther Med. 2021 Dec;22(6):1430. doi: 10.3892/etm.2021.10865. Epub 2021 Oct 11.
4
Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases.非编码 RNA:胰岛素抵抗及相关疾病的新角色。
Int J Mol Sci. 2021 Jul 19;22(14):7716. doi: 10.3390/ijms22147716.
5
miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation.肝移植后 6 个月 HCV 和 HIV/HCV 感染受者肝移植物中的 miRNA 表达谱。
J Med Virol. 2021 Aug;93(8):4992-5000. doi: 10.1002/jmv.26999. Epub 2021 May 4.
6
Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers.非酒精性脂肪性肝病中的非编码 RNA:潜在的诊断和预后生物标志物。
Dis Markers. 2020 Aug 27;2020:8822859. doi: 10.1155/2020/8822859. eCollection 2020.
7
Mechanism of the Regulatory Effect of Overexpression of circMTO1 on Proliferation and Apoptosis of Hepatoma Cells via miR-9-5p/NOX4 Axis.环状MTO1过表达通过miR-9-5p/NOX4轴对肝癌细胞增殖和凋亡的调控作用机制
Cancer Manag Res. 2020 May 26;12:3915-3925. doi: 10.2147/CMAR.S240719. eCollection 2020.
8
Green Tea Prevents NAFLD by Modulation of miR-34a and miR-194 Expression in a High-Fat Diet Mouse Model.绿茶通过调节高脂肪饮食诱导的 NAFLD 模型中 miR-34a 和 miR-194 的表达来预防非酒精性脂肪性肝病。
Oxid Med Cell Longev. 2019 Dec 4;2019:4168380. doi: 10.1155/2019/4168380. eCollection 2019.
9
MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patients.微小RNA-122a作为埃及患者丙型肝炎病毒4型相关肝细胞癌的非侵入性生物标志物
Arch Med Sci. 2019 Oct;15(6):1454-1461. doi: 10.5114/aoms.2019.86621. Epub 2019 Jul 17.
10
Plasma microRNA: A novel non-invasive biomarker for HBV-associated liver fibrosis staging.血浆微小RNA:一种用于乙肝相关肝纤维化分期的新型非侵入性生物标志物。
Exp Ther Med. 2019 Mar;17(3):1919-1929. doi: 10.3892/etm.2018.7117. Epub 2018 Dec 19.

本文引用的文献

1
miRNA regulation of liver growth after 50% partial hepatectomy and small size grafts in rats.miRNA 对大鼠 50%部分肝切除和小体积移植物后肝生长的调控。
Transplantation. 2011 Feb 15;91(3):293-9. doi: 10.1097/TP.0b013e318204756c.
2
Regulation and biological function of the liver-specific miR-122.肝脏特异性 miR-122 的调控和生物学功能。
Biochem Soc Trans. 2010 Dec;38(6):1553-7. doi: 10.1042/BST0381553.
3
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha.聚乙二醇干扰素α治疗慢性丙型肝炎病毒感染患者中干扰素诱导的 microRNAs 的差异表达。
Virol J. 2010 Nov 12;7:311. doi: 10.1186/1743-422X-7-311.
4
MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes.微小 RNA 对肿瘤抑制因子 DLC-1 的沉默促进了丙型肝炎病毒在原代人肝细胞中的有效复制。
Hepatology. 2011 Jan;53(1):53-61. doi: 10.1002/hep.24016. Epub 2010 Oct 21.
5
Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases.血浆 microRNA-122 作为病毒、酒精和化学性肝疾病的生物标志物。
Clin Chem. 2010 Dec;56(12):1830-8. doi: 10.1373/clinchem.2010.147850. Epub 2010 Oct 7.
6
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.MicroRNA 谱分析显示 miR-29 在人类和鼠类肝纤维化中起作用。
Hepatology. 2011 Jan;53(1):209-18. doi: 10.1002/hep.23922. Epub 2010 Oct 1.
7
Tissue-specific regulation of mouse microRNA genes in endoderm-derived tissues.组织特异性调控小鼠内胚层衍生组织中的 microRNA 基因。
Nucleic Acids Res. 2011 Jan;39(2):454-63. doi: 10.1093/nar/gkq782. Epub 2010 Sep 14.
8
Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development.富含肝的转录因子调节 microRNA-122,该 microRNA-122 在肝发育过程中靶向 CUTL1。
Hepatology. 2010 Oct;52(4):1431-42. doi: 10.1002/hep.23818.
9
Parallel microRNA and mRNA expression profiling of (genotype 1b) human hepatoma cells expressing hepatitis C virus.(基因型 1b)表达丙型肝炎病毒的人肝癌细胞的平行 microRNA 和 mRNA 表达谱分析。
Liver Int. 2010 Nov;30(10):1490-504. doi: 10.1111/j.1478-3231.2010.02321.x. Epub 2010 Sep 1.
10
Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid.部分肝切除术后大鼠肝再生过程中 microRNAs 的鉴定及熊去氧胆酸的调控作用。
Am J Physiol Gastrointest Liver Physiol. 2010 Oct;299(4):G887-97. doi: 10.1152/ajpgi.00216.2010. Epub 2010 Aug 5.